CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells

Rohin I. on LinkedIn: CAR density influences antitumoral efficacy of BCMA CAR T cells and…

CAR T-cell therapy for patients with multiple myeloma

Frontiers Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions

Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies

CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells and Correlates with Clinical Outcome

Biology and status of chimeric antigen receptor-engineered T cell therapy - ScienceDirect

BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma

CTLA-4 tail fusion enhances CAR-T anti-tumor immunity

CAR Density Influences Antitumoral Efficacy of BCMA CAR T cells and Correlates with Clinical Outcome

PDF] Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response

The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19 - Cytotherapy

Physiological lentiviral vectors for the generation of improved CAR-T cells - ScienceDirect

Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors